AustinPx is a client-centric CDMO based in Georgetown, Texas, specializing in oral solid dosage formulation development and GMP manufacturing for preclinical through Phase II clinical supplies. They are the inventors of KinetiSol technology, a next-generation solvent-free amorphous solid dispersion (ASD) technology for poorly soluble APIs that offers a smaller ecological footprint and broader formulation design space compared to traditional methods like hot melt extrusion and spray drying. AustinPx provides technology-nonbiased, data-driven formulation strategies, with KinetiSol as a proprietary differentiation tool. They received the CPHI Accelerating Innovation Award and CPHI Pharma Award for Excellence in Drug Delivery Technologies in 2024.
amorphous solid dispersions (ASD), KinetiSol technology, oral bioavailability enhancement, poorly soluble APIs, formulation development, solvent-free pharmaceutical processing
1 site worldwide
No reviews available yet.
No documents available.